Akoya Biosciences (AKYA) Insider Trading & Ownership $1.10 -0.09 (-7.56%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Akoya Biosciences (NASDAQ:AKYA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$30,675.00 Get AKYA Insider Trade Alerts Want to know when executives and insiders are buying or selling Akoya Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AKYA Insider Buying and Selling by Quarter Remove Ads Akoya Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/11/2024Brian MckelligonCEOSell7,500$2.08$15,600.00 6/6/2024Brian MckelligonCEOSell7,500$2.01$15,075.00 (Data available from 1/1/2013 forward) AKYA Insider Trading Activity - Frequently Asked Questions Who is on Akoya Biosciences's Insider Roster? The list of insiders at Akoya Biosciences includes Brian Mckelligon, Frederic Pla, Garry Ph.D. Nolan, John Frederick Ek, Joseph Driscoll, and Matthew Winkler. Learn more on insiders at AKYA. What percentage of Akoya Biosciences stock is owned by insiders? 7.30% of Akoya Biosciences stock is owned by insiders. Learn more on AKYA's insider holdings. Which Akoya Biosciences insiders have been buying company stock? The following insiders have purchased AKYA shares in the last 24 months: Frederic Pla ($92,000.00), John Frederick Ek ($100,000.00), and Matthew Winkler ($1,016,940.00). How much insider buying is happening at Akoya Biosciences? Insiders have purchased a total of 243,388 AKYA shares in the last 24 months for a total of $1,208,940.00 bought. Which Akoya Biosciences insiders have been selling company stock? The following insider sold AKYA shares in the last 24 months: Brian Mckelligon ($167,150.00). How much insider selling is happening at Akoya Biosciences? Insiders have sold a total of 42,500 Akoya Biosciences shares in the last 24 months for a total of $167,150.00 sold. Akoya Biosciences Key ExecutivesMr. Brian McKelligon (Age 55)President, CEO & Director Compensation: $854.99kMr. John Frederick Ek (Age 48)CFO, Principal Financial Officer & Principal Accounting Officer Compensation: $496.76kDr. Frederic G. Pla Ph.D. (Age 65)Chief Operating Officer Compensation: $581.23kPriyam ShahSenior Director of Business Development & Investor Relations StrategyMs. Jennifer Kamocsay (Age 53)General Counsel Dr. Niro Ramachandran Ph.D. (Age 49)Chief Business Officer Compensation: $298.18kDr. Pascal Bamford Ph.D.Senior Vice President, Research & Development and Laboratory OperationsMr. Rob C. Hart CFAJ.D., Secretary More Insider Trading Tools from MarketBeat Related Companies Aehr Test Systems Insider Ownership Quantum-Si Insider Ownership Quanterix Insider Ownership Frequency Electronics Insider Ownership 908 Devices Insider Ownership Seer Insider Ownership Kewaunee Scientific Insider Ownership Nautilus Biotechnology Insider Ownership Odysight.Ai Insider Ownership Rapid Micro Biosystems Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:AKYA) was last updated on 4/16/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akoya Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akoya Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
